The Allergy Academy is proud to be collaborating with prominent leaders in paediatric allergy to discuss the implications of NICE's recent Final Appraisal Document announcement for oral peanut immunotherapy. This will be of relevance to the wider allergy community being the first approved and validated oral food immunotherapy option to be made publically available.

This free, online event will provide context, information and a forum for questions. We look forward to welcoming you for what will sure to be fruitful discussions at this exciting time for our specialty!